Importance of the major splice donor and redefinition of cis-acting sequences of gutless feline foamy virus vectors

Virology

Volumn 394, Issue 2, 2009, Pages 208-217

  Liu, Weibin ^a   Backes, Perdita ^a   Löchelt, Martin ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

cis Acting element; Gene therapy; RNA splicing; Spumavirus; Vector

Indexed keywords

CIS ACTING ELEMENT; GAG PROTEIN; POL PROTEIN; VIRUS VECTOR;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FELINE FOAMY VIRUS; GENE DELETION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN EXPRESSION; RNA SPLICING; RNA VECTOR; SITE DIRECTED MUTAGENESIS; START CODON; TRANSGENE; VIRUS GENOME;

5' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CATS; CELL LINE; GENE THERAPY; GENES, GAG; GENES, POL; GENETIC VECTORS; HUMANS; MUTAGENESIS, SITE-DIRECTED; NUCLEIC ACID CONFORMATION; RNA SPLICE SITES; RNA, VIRAL; SPUMAVIRUS; TRANSFECTION; VIRUS ASSEMBLY; VIRUS INTEGRATION; VIRUS REPLICATION;

FELINE FOAMY VIRUS; HUMAN SPUMARETROVIRUS; SPUMAVIRUS;

EID: 70449084700     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.08.028     Document Type: Article

References (39)

1. Alke A., Schwantes A., Kido K., Flötenmeyer M., Flügel R.M., and Löchelt M. The bet gene of feline foamy virus is required for virus replication. Virology 287 2 (2001) 310-320
2. Baldwin D.N., and Linial M.L. The roles of Pol and Env in the assembly pathway of human foamy virus. J. Virol. 72 5 (1998) 3658-3665
3. Bastone P., Bravo I.G., and Löchelt M. Feline foamy virus-mediated marker gene transfer: identification of essential genetic elements and influence of truncated and chimeric proteins. Virology 348 1 (2006) 190-199
4. Bastone P., Romen F., Liu W., Wirtz R., Koch U., Josephson N., Langbein S., and Löchelt M. Construction and characterization of efficient, stable and safe replication-deficient foamy virus vectors. Gene Ther. 14 7 (2007) 613-620
5. Bauer T.R., Allen J.M., Hai M., Tuschong L.M., Khan I.F., Olson E.M., Adler R.L., Burkholder T.H., Gu Y.C., Russell D.W., and Hickstein D.D. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat. Med. 14 1 (2008) 93-97
6. Bodem J., Löchelt M., Winkler I., Flower R.P., Delius H., and Flügel R.M. Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J. Virol. 70 12 (1996) 9024-9027
7. Cui Y., Iwakuma T., and Chang L.J. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function. J. Virol. 73 7 (1999) 6171-6176
8. Cullen B.R. Nuclear mRNA export: insights from virology. Trends Biochem. Sci. 28 8 (2003) 419-424
9. Geiselhart V., Schwantes A., Bastone P., Frech M., and Löchelt M. Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology 310 2 (2003) 235-244
10. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., and Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302 5644 (2003) 415-419
11. Heinkelein M., Schmidt M., Fischer N., Moebes A., Lindemann D., Enssle J., and Rethwilm A. Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J. Virol. 72 8 (1998) 6307-6314
12. Heinkelein M., Thurow J., Dressler M., Imrich H., Neumann-Haefelin D., McClure M.O., and Rethwilm A. Complex effects of deletions in the 5′ untranslated region of primate foamy virus on viral gene expression and RNA packaging. J. Virol. 74 7 (2000) 3141-3148
13. Heinkelein M., Dressler M., Jarmy G., Rammling M., Imrich H., Thurow J., Lindemann D., and Rethwilm A. Improved primate foamy virus vectors and packaging constructs. J. Virol. 76 8 (2002) 3774-3783
14. Kaiser J. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science 299 5606 (2003) 495
15. Kiem H.P., Allen J., Trobridge G., Olson E., Keyser K., Peterson L., and Russell D.W. Foamy-virus-mediated gene transfer to canine repopulating cells. Blood 109 1 (2007) 65-70
16. Linial M. Foamy viruses. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology. 5th ed. vol. 2 (2007), Lippincott Williams and Wilkins, Philadelphia
17. Löchelt M. Foamy virus transactivation and gene expression. Curr. Top. Microbiol. Immunol. 277 (2003) 27-61
18. Lutzelberger M., Reinert L.S., Das A.T., Berkhout B., and Kjems J. A novel splice donor site in the gag-pol gene is required for HIV-1 RNA stability. J. Biol. Chem. 281 27 (2006) 18644-18651
19. Mergia A., and Heinkelein M. Foamy virus vectors. Curr. Top. Microbiol. Immunol. 277 (2003) 131-159
20. Nowrouzi A., Dittrich M., Klanke C., Heinkelein M., Rammling M., Dandekar T., von Kalle C., and Rethwilm A. Genome-wide mapping of foamy virus vector integrations into a human cell line. J. Gen. Virol. 87 Pt 5 (2006) 1339-1347
21. Peters K., Wiktorowicz T., Heinkelein M., and Rethwilm A. RNA and protein requirements for incorporation of the Pol protein into foamy virus particles. J. Virol. 79 11 (2005) 7005-7013
22. Pfeifer A., and Verma I.M. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet. 2 (2001) 177-211
23. Pietschmann T., Heinkelein M., Heldmann M., Zentgraf H., Rethwilm A., and Lindemann D. Foamy virus capsids require the cognate envelope protein for particle export. J. Virol. 73 4 (1999) 2613-2621
24. Popa I., Harris M.E., Donello J.E., and Hope T.J. CRM1-dependent function of a cis-acting RNA export element. Mol. Cell. Biol. 22 7 (2002) 2057-2067
25. Rethwilm A. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr. Gene Ther. 7 4 (2007) 261-271
26. Russell R.A., Zeng Y., Erlwein O., Cullen B.R., and McClure M.O. The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression. J. Virol. 75 15 (2001) 6817-6824
27. Schambach A., Bohne J., Baum C., Hermann F.G., Egerer L., von Laer D., and Giroglou T. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 13 7 (2006) 641-645
28. Schambach A., Mueller D., Galla M., Verstegen M.M., Wagemaker G., Loew R., Baum C., and Bohne J. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Ther. 13 21 (2006) 1524-1533
29. Schwantes A., Ortlepp I., and Löchelt M. Construction and functional characterization of feline foamy virus-based retroviral vectors. Virology 301 1 (2002) 53-63
30. Schwantes A., Truyen U., Weikel J., Weiss C., and Löchelt M. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats. J. Virol. 77 14 (2003) 7830-7842
31. Trobridge G., Josephson N., Vassilopoulos G., Mac J., and Russell D.W. Improved foamy virus vectors with minimal viral sequences. Mol. Ther. 6 3 (2002) 321-328
32. Trobridge G.D., Miller D.G., Jacobs M.A., Allen J.M., Kiem H.P., Kaul R., and Russell D.W. Foamy virus vector integration sites in normal human cells. Proc. Natl. Acad. Sci. U.S.A. 103 5 (2006) 1498-1503
33. Wagner A., Doerks A., Aboud M., Alonso A., Tokino T., Flügel R.M., and Löchelt M. Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells. J. Virol. 74 10 (2000) 4441-4447
34. Wiktorowicz T., Peters K., Armbruster N., Steinert A.F., and Rethwilm A. Generation of an improved foamy virus vector by dissection of cis-acting sequences. J. Gen. Virol. 90 Pt 2 (2009) 481-487
35. Winkler I., Bodem J., Haas L., Zemba M., Delius H., Flower R., Flügel R.M., and Löchelt M. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J. Virol. 71 9 (1997) 6727-6741
36. Wu M., Chari S., Yanchis T., and Mergia A. cis-Acting sequences required for simian foamy virus type 1 vectors. J. Virol. 72 4 (1998) 3451-3454
37. Yu S.F., Baldwin D.N., Gwynn S.R., Yendapalli S., and Linial M.L. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271 5255 (1996) 1579-1582
38. Yu S.F., Sullivan M.D., and Linial M.L. Evidence that the human foamy virus genome is DNA. J. Virol. 73 2 (1999) 1565-1572
39. Zemba M., Alke A., Bodem J., Winkler I.G., Flower R.L., Pfrepper K., Delius H., Flügel R.M., and Löchelt M. Construction of infectious feline foamy virus genomes: cat antisera do not cross-neutralize feline foamy virus chimera with serotype-specific Env sequences. Virology 266 1 (2000) 150-156